200,000+ products from a single source!

sales@angenechem.com

Home > Pyridines > 848591-89-9

848591-89-9

848591-89-9 | Pyrrolo[3,4-c]pyrrole, octahydro-2-Methyl-5-(6-phenyl-3-pyridazinyl)-

CAS No: 848591-89-9 Catalog No: AG00GAOX MDL No:MFCD22572950

Product Description

Catalog Number:
AG00GAOX
Chemical Name:
Pyrrolo[3,4-c]pyrrole, octahydro-2-Methyl-5-(6-phenyl-3-pyridazinyl)-
CAS Number:
848591-89-9
Molecular Formula:
C17H20N4
Molecular Weight:
280.3675
MDL Number:
MFCD22572950
IUPAC Name:
2-methyl-5-(6-phenylpyridazin-3-yl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole
InChI:
InChI=1S/C17H20N4/c1-20-9-14-11-21(12-15(14)10-20)17-8-7-16(18-19-17)13-5-3-2-4-6-13/h2-8,14-15H,9-12H2,1H3
InChI Key:
GTMRUYCIJSNXGB-UHFFFAOYSA-N
SMILES:
CN1CC2C(C1)CN(C2)c1ccc(nn1)c1ccccc1

Properties

Complexity:
341  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
280.169g/mol
Formal Charge:
0
Heavy Atom Count:
21  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
280.375g/mol
Monoisotopic Mass:
280.169g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
32.3A^2
Undefined Atom Stereocenter Count:
2  
Undefined Bond Stereocenter Count:
0
XLogP3:
2.1  

Literature

Title Journal
Discovery and development of α7 nicotinic acetylcholine receptor modulators. Journal of medicinal chemistry 20111208
Differential immediate and sustained memory enhancing effects of alpha7 nicotinic receptor agonists and allosteric modulators in rats. PloS one 20110101
Repeated administration of alpha7 nicotinic acetylcholine receptor (nAChR) agonists, but not positive allosteric modulators, increases alpha7 nAChR levels in the brain. Journal of neurochemistry 20100801
In vivo evaluation of alpha7 nicotinic acetylcholine receptor agonists [11C]A-582941 and [11C]A-844606 in mice and conscious monkeys. PloS one 20100101
Role of channel activation in cognitive enhancement mediated by alpha7 nicotinic acetylcholine receptors. British journal of pharmacology 20091101
Selective alpha7 nicotinic acetylcholine receptor activation regulates glycogen synthase kinase3beta and decreases tau phosphorylation in vivo. Brain research 20090410
Alpha7 nicotinic acetylcholine receptor activation ameliorates scopolamine-induced behavioural changes in a modified continuous Y-maze task in mice. European journal of pharmacology 20090105
The selective alpha7 nicotinic acetylcholine receptor agonist A-582941 activates immediate early genes in limbic regions of the forebrain: Differential effects in the juvenile and adult rat. Neuroscience 20080623
Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties. CNS neuroscience & therapeutics 20080101
Profile of nicotinic acetylcholine receptor agonists ABT-594 and A-582941, with differential subtype selectivity, on delayed matching accuracy by young monkeys. Biochemical pharmacology 20071015
Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways. The Journal of neuroscience : the official journal of the Society for Neuroscience 20070926

© 2019 Angene International Limited. All rights Reserved.